Antonio Paul on Blame Game in Transplantation: HLA vs Microbes
Antonio Paul, Head of ACTIMoS- Advanced Center for Transplant Immunology and Molecular Science, shared on LinkedIn:
”Blame Game in Transplantation: HLA vs Microbes
What if HLA antibodies are not always about HLA?
For decades, we’ve taught that anti-HLA antibodies arise from the usual suspects:
- Prior transplants
- Blood transfusions
- Pregnancy
But many patients develop de novo anti-HLA antibodies without any classic sensitization history.
Growing evidence suggests another culprit: Infections.
What’s happening?
Microbes can trigger HLA antibodies through several mechanisms:
- Molecular mimicry – Microbial antigens may resemble HLA epitopes, leading to cross-reactive antibodies.
- Innate immune “danger signals” – Toll-like receptor activation can break immune tolerance and promote rejection.
- Bystander B-cell activation – Cytokine surges during infection can awaken dormant HLA-reactive memory B cells.
- Polyclonal immune activation – Broad antibody expansion may occur after infections or vaccinations.
Clinical evidence shows that infections often precede:
– Increased panel reactive antibodies (PRA)
– Emergence of donor-specific antibodies (DSA)
– Higher rejection risk
– Poorer graft survival
Rethinking an old assumption
Not all HLA antibodies are born from mismatched HLA.
Some may be born from mismatched microbes.
Transplant success may depend not only on how well donors and recipients are matched, but also on which microbes the immune system remembers.”

Stay updated with Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’